Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of selling price gouging, declaring the stark distinction amongst U.S. rates and those in Europe and copyright.California biotech behemoth Amgen ditched ideas for an experimental weight loss capsule in May perhap